Home » Authors » James Etheridge

Articles by James Etheridge

Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia

June 18, 2008

By James Etheridge

SiRNAsense Picks Polyplus's in Vivo Delivery Platform

June 18, 2008

By James Etheridge

Transgene's TG4010 Vaccine Meets Phase IIb Trial Endpoint

June 11, 2008

By James Etheridge

Edmond de Rothschild Closes 150 Million BioDiscovery Fund

June 4, 2008

By James Etheridge

Innate Launches Preclinical Work on First Antibody in Novo Deal

June 4, 2008

By James Etheridge

BioAlliance Buys Rights to NovaDel's Ondansetron

May 28, 2008

By James Etheridge

Trophos Launches Phase II Trial of TRO19622 in Liver Disease

May 21, 2008

By James Etheridge

NicOx Antihypertensive Taken Into Phase I Trial by Merck

May 14, 2008

By James Etheridge

Polyplus-transfection Unveils New siRNA Technology

April 30, 2008

By James Etheridge

Sanofi-Aventis Stops Developing Two Genfit Drug Candidates

April 9, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...